Detail page

Knowledge Web

Person

Dimitrios Mougiakakos (1979-)

Arzt

Name	Dimitrios Mougiakakos
Time	1979- (Date of birth and death)
Place	Griechenland
Gender	männlich
Profession	Arzt (characteristic profession)
Related	Medizinische Hochschule Hannover
Further information	Diss. Medizin (Abt. für Hämatologie und Onkologie) an der Medizinischen Hochschule Hannover; Prof. Dr. Lehrstuhl für Hämatologie/Internistische Onkologie, FAU Erlangen-Nürnberg (ab 2017)
Source	AM Metadaten
Record type	Person
GND-Identifier	132997673
Record ID	132997673
Involved in show all Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas Synergistic lethality in chronic myeloid leukemia – targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment AML consolidation therapy: timing matters CT-defined sarcopenia predicts treatment response in primary central nervous system lymphomas Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience Outcomes of axicabtagene ciloleucel in PMBCL compare favorably to DLBCL: a GLA/DRST registry study Therapie des multiplen Myeloms : eine retrospektive Analyse von 185 konsekutiven Patienten mit besonderer Berücksichtigung der autologen Hochdosis-Chemotherapie Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome Anticancer Aminoferrocene Derivatives Inducing Production of Mitochondrial Reactive Oxygen Species CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints Lipotoxicity as a Barrier for T Cell-Based Therapies Role of CAR T Cell Metabolism for Therapeutic Efficacy Therapie der chronischen myeloischen Leukämie in einer hämatologischen Schwerpunktpraxis mit Fokus auf Tyrosinkinaseinhibitor-Absetzversuche Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas Einfluss des Knochenmarkstromas auf den Metabolismus der akuten myeloischen Leukämie Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden Methylcholanthrene-Induced Sarcomas Develop Independently from NOX2-Derived ROS Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden Comparative Expression Profiling of Distinct T Cell Subsets Undergoing Oxidative Stress Quantitative, phänotypische und funktionelle Analyse von dendritischen Zellen des peripheren Blutes bei pädiatrischen Patienten mit akuter lymphoblastischer Leukämie Quantitative, phänotypische und funktionelle Analyse von dendritischen Zellen des peripheren Blutes bei pädiatrischen Patienten mit akuter lymphoblastischer Leukämie

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Dimitrios Mougiakakos (1979-)

Neutrophil-specific expression of JAK2-V617F or CALRmut induces distinct inflammatory profiles in myeloproliferative neoplasia

Activating mutations in JAK2 and CALR differentially affect intracellular calcium flux in store operated calcium entry

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Synergistic lethality in chronic myeloid leukemia – targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment

AML consolidation therapy: timing matters

CT-defined sarcopenia predicts treatment response in primary central nervous system lymphomas

Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib

Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma

Effects of the STAMP-inhibitor asciminib on T cell activation and metabolic fitness compared to tyrosine kinase inhibition by imatinib, dasatinib, and nilotinib

Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience

Outcomes of axicabtagene ciloleucel in PMBCL compare favorably to DLBCL: a GLA/DRST registry study

Therapie des multiplen Myeloms : eine retrospektive Analyse von 185 konsekutiven Patienten mit besonderer Berücksichtigung der autologen Hochdosis-Chemotherapie

Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience

The metabolic profile of reconstituting T-cells, NK-cells, and monocytes following autologous stem cell transplantation and its impact on outcome

Anticancer Aminoferrocene Derivatives Inducing Production of Mitochondrial Reactive Oxygen Species

CLL-Derived Extracellular Vesicles Impair T-Cell Activation and Foster T-Cell Exhaustion via Multiple Immunological Checkpoints

Lipotoxicity as a Barrier for T Cell-Based Therapies

Role of CAR T Cell Metabolism for Therapeutic Efficacy

Therapie der chronischen myeloischen Leukämie in einer hämatologischen Schwerpunktpraxis mit Fokus auf Tyrosinkinaseinhibitor-Absetzversuche

Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas

Einfluss des Knochenmarkstromas auf den Metabolismus der akuten myeloischen Leukämie

Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden

Methylcholanthrene-Induced Sarcomas Develop Independently from NOX2-Derived ROS

Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden

Comparative Expression Profiling of Distinct T Cell Subsets Undergoing Oxidative Stress

Quantitative, phänotypische und funktionelle Analyse von dendritischen Zellen des peripheren Blutes bei pädiatrischen Patienten mit akuter lymphoblastischer Leukämie

Quantitative, phänotypische und funktionelle Analyse von dendritischen Zellen des peripheren Blutes bei pädiatrischen Patienten mit akuter lymphoblastischer Leukämie